{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:02:51Z","timestamp":1792026171468,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Pre-research Fund of the Second Affiliated Hospital of Soochow University","award":["SDFEYJGL2102"],"award-info":[{"award-number":["SDFEYJGL2102"]}]},{"name":"Suzhou Medical Health Science and Technology Innovation Project","award":["SKY2022146"],"award-info":[{"award-number":["SKY2022146"]}]},{"name":"Suzhou Health and Key Talent Project","award":["GSWS2019011"],"award-info":[{"award-number":["GSWS2019011"]}]},{"name":"Jiangsu Provincial Health Key Research and Development Project","award":["ZD2022032"],"award-info":[{"award-number":["ZD2022032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10067-024-07298-4","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T08:03:20Z","timestamp":1735891400000},"page":"767-774","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies"],"prefix":"10.1007","volume":"44","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghua","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leixi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9766-1656","authenticated-orcid":false,"given":"Zhichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"5","key":"7298_CR1","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"R Aggarwal","year":"2017","unstructured":"Aggarwal R, Rider LG, Ruperto N et al (2017) 2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 76(5):792\u2013801","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"7298_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G (2024) Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol 20(1):48\u201362","journal-title":"Nat Rev Rheumatol"},{"issue":"4\u20135","key":"7298_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","volume":"13","author":"M Mahler","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ (2014) Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev 13(4\u20135):367\u2013371","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7298_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/1744666X.2019.1699059","volume":"16","author":"T Gono","year":"2020","unstructured":"Gono T, Kuwana M (2020) Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis. Expert Rev Clin Immunol 16(1):79\u201389","journal-title":"Expert Rev Clin Immunol"},{"key":"7298_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.987841","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang L, Jin Q et al (2022) The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients. Front Immunol 13:987841","journal-title":"Front Immunol"},{"issue":"2","key":"7298_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3899\/jrheum.220139","volume":"50","author":"C Lv","year":"2023","unstructured":"Lv C, You H, Xu L et al (2023) Coexistence of anti-Ro52 antibodies in anti-MDA5 antibody-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk. J Rheumatol 50(2):219\u2013226","journal-title":"J Rheumatol"},{"issue":"1","key":"7298_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s10067-023-06816-0","volume":"43","author":"L Cheng","year":"2024","unstructured":"Cheng L, Xu L, Xu Y et al (2024) Gender differences in patients with anti-MDA5-positive dermatomyositis: a cohort study of 251 cases. Clin Rheumatol 43(1):339\u2013347","journal-title":"Clin Rheumatol"},{"issue":"4","key":"7298_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.42308","volume":"75","author":"L Xu","year":"2023","unstructured":"Xu L, You H, Wang L et al (2023) Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease. Arthritis Rheumatol (Hoboken, N.J.) 75(4):609\u201319","journal-title":"Arthritis Rheumatol (Hoboken, N.J.)"},{"key":"7298_CR9","doi-asserted-by":"publisher","first-page":"1286973","DOI":"10.3389\/fimmu.2024.1286973","volume":"15","author":"L Wang","year":"2024","unstructured":"Wang L, Lv C, You H et al (2024) Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model. Front Immunol 15:1286973","journal-title":"Front Immunol"},{"issue":"8","key":"7298_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"issue":"7","key":"7298_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"3","key":"7298_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s003300000648","volume":"11","author":"C Schaefer-Prokop","year":"2001","unstructured":"Schaefer-Prokop C, Prokop M, Fleischmann D et al (2001) High-resolution CT of diffuse interstitial lung disease: key findings in common disorders. Eur Radiol 11(3):373\u2013392","journal-title":"Eur Radiol"},{"issue":"4","key":"7298_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/kez357","volume":"59","author":"Y Abe","year":"2020","unstructured":"Abe Y, Kusaoi M, Tada K et al (2020) Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology (Oxford) 59(4):767\u2013771","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7298_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.rmed.2007.02.017","volume":"101","author":"J Won Huh","year":"2007","unstructured":"Won Huh J, Soon Kim D, Keun Lee C et al (2007) Two distinct clinical types of interstitial lung disease associated with polymyositis-dermatomyositis. Respir Med 101(8):1761\u20131769","journal-title":"Respir Med"},{"key":"7298_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152231","volume":"62","author":"H Xie","year":"2023","unstructured":"Xie H, Zhang D, Wang Y et al (2023) Risk factors for mortality in patients with anti-MDA5 antibody-positive dermatomyositis: a meta-analysis and systematic review. Semin Arthritis Rheum 62:152231","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 1","key":"7298_CR16","first-page":"141","volume":"9","author":"H Yoshifuji","year":"2015","unstructured":"Yoshifuji H (2015) Biomarkers and autoantibodies of interstitial lung disease with idiopathic inflammatory myopathies. Clin Med Insights: Circ Respir Pulm Med 9(Suppl 1):141\u20136","journal-title":"Clin Med Insights: Circ Respir Pulm Med"},{"issue":"4","key":"7298_CR17","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q et al (2020) Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: The FLAIR Model. Chest 158(4):1535\u20131545","journal-title":"Chest"},{"issue":"6","key":"7298_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s100670050139","volume":"18","author":"M Ito","year":"1999","unstructured":"Ito M, Kaise S, Suzuki S et al (1999) Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol 18(6):462\u2013467","journal-title":"Clin Rheumatol"},{"key":"7298_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.908365","volume":"9","author":"Q Niu","year":"2022","unstructured":"Niu Q, Zhao LQ, Ma WL et al (2022) A new predictive model for the prognosis of MDA5(+) DM-ILD. Front Med 9:908365","journal-title":"Front Med"},{"key":"7298_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-94-017-7215-0_8","volume":"867","author":"V Jurisic","year":"2015","unstructured":"Jurisic V, Radenkovic S, Konjevic G (2015) The actual role of LDH as tumor marker, biochemical and clinical aspects. Adv Exp Med Biol 867:115\u2013124","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"7298_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12890-022-02106-8","volume":"22","author":"T Liu","year":"2022","unstructured":"Liu T, Li W, Zhang Z et al (2022) Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis. BMC Pulm Med 22(1):316","journal-title":"BMC Pulm Med"},{"issue":"2","key":"7298_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol 60(2):293\u2013304","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"7298_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120313","volume":"10","author":"H Hozumi","year":"2015","unstructured":"Hozumi H, Enomoto N, Kono M et al (2015) Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS ONE 10(3):e0120313","journal-title":"PLoS ONE"},{"issue":"1","key":"7298_CR24","volume":"41","author":"M Mima","year":"2024","unstructured":"Mima M, Sato S, Shinya T et al (2024) Characteristics of chest high-resolution computed tomography in patients with anti-aminoacyl-tRNA synthetase antibody-positive interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis: Official J WASOG 41(1):e2024005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis: Official J WASOG"},{"issue":"5","key":"7298_CR25","first-page":"1012","volume":"34","author":"T Matsushita","year":"2007","unstructured":"Matsushita T, Hasegawa M, Fujimoto M et al (2007) Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 34(5):1012\u20131018","journal-title":"J Rheumatol"},{"issue":"8","key":"7298_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00296-017-3729-y","volume":"37","author":"K Isoda","year":"2017","unstructured":"Isoda K, Kotani T, Takeuchi T et al (2017) Comparison of long-term prognosis and relapse of dermatomyositis complicated with interstitial pneumonia according to autoantibodies: anti-aminoacyl tRNA synthetase antibodies versus anti-melanoma differentiation-associated gene 5 antibody. Rheumatol Int 37(8):1335\u20131340","journal-title":"Rheumatol Int"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07298-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07298-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07298-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:31:41Z","timestamp":1738045901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07298-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7298"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07298-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The study methods were approved by the Ethics Committee Board of the Second Affiliated Hospital of Soochow University (Approval No. JD-HG-2023\u201309).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}